Comment on ‘A phase III randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer— GRECCAR 17 trial protocol’
- 4 November 2025
- journal article
- Published by Wiley in Colorectal Disease
- Vol. 27 (11) , e70300
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- A phase III randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer—GRECCAR 17 trial protocolColorectal Disease, 2022
- Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal ExcisionAnnals of Surgery, 2019